NO175846C - Fremgangsmåte for å oppnå et immunogen - Google Patents

Fremgangsmåte for å oppnå et immunogen

Info

Publication number
NO175846C
NO175846C NO890565A NO890565A NO175846C NO 175846 C NO175846 C NO 175846C NO 890565 A NO890565 A NO 890565A NO 890565 A NO890565 A NO 890565A NO 175846 C NO175846 C NO 175846C
Authority
NO
Norway
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
NO890565A
Other languages
English (en)
Norwegian (no)
Other versions
NO175846B (de
NO890565D0 (no
NO890565L (no
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of NO890565D0 publication Critical patent/NO890565D0/no
Publication of NO890565L publication Critical patent/NO890565L/no
Publication of NO175846B publication Critical patent/NO175846B/no
Publication of NO175846C publication Critical patent/NO175846C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
NO890565A 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen NO175846C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (4)

Publication Number Publication Date
NO890565D0 NO890565D0 (no) 1989-02-09
NO890565L NO890565L (no) 1989-02-09
NO175846B NO175846B (de) 1994-09-12
NO175846C true NO175846C (no) 1994-12-21

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890565A NO175846C (no) 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen

Country Status (14)

Country Link
EP (3) EP0602761A1 (de)
JP (1) JPH0720880B2 (de)
AT (1) ATE132374T1 (de)
AU (1) AU612383B2 (de)
CA (1) CA1336407C (de)
DE (1) DE3854857T2 (de)
DK (1) DK56389D0 (de)
FI (1) FI95871C (de)
IL (1) IL86675A (de)
NO (1) NO175846C (de)
OA (1) OA09037A (de)
RU (1) RU2111010C1 (de)
UA (1) UA27716C2 (de)
WO (1) WO1988009670A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ES2141929T3 (es) * 1994-03-22 2000-04-01 Immune Response Corp Inc Produccion y aislamiento muy eficientes de particulas viricas.
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
EP0187041B1 (de) * 1984-12-24 1996-05-15 Genentech, Inc. Fusionen von AIDS-verwandten Polypeptiden
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
EP0249611A4 (de) * 1985-11-14 1988-04-26 Harvard College T-lymphotrophisches virus.
EP0250128A3 (de) * 1986-06-18 1988-06-08 American Registry of Pathology Von AIDS-Patienten isoliertes Virus
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
JPH02500440A (ja) 1990-02-15
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
NO175846B (de) 1994-09-12
CA1336407C (en) 1995-07-25
FI890603A (fi) 1989-02-08
FI95871C (fi) 1996-04-10
ATE132374T1 (de) 1996-01-15
AU612383B2 (en) 1991-07-11
FI890603A0 (fi) 1989-02-08
OA09037A (en) 1991-03-31
JPH0720880B2 (ja) 1995-03-08
AU1962688A (en) 1989-01-04
UA27716C2 (uk) 2000-10-16
EP0602761A1 (de) 1994-06-22
EP0317622A1 (de) 1989-05-31
EP0317622A4 (de) 1990-05-14
DE3854857T2 (de) 1996-08-22
NO890565D0 (no) 1989-02-09
EP0685236A1 (de) 1995-12-06
FI95871B (fi) 1995-12-29
NO890565L (no) 1989-02-09
IL86675A (en) 1993-04-04
EP0317622B1 (de) 1996-01-03
WO1988009670A1 (en) 1988-12-15
RU2111010C1 (ru) 1998-05-20
DK56389D0 (da) 1989-02-08

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DK0778888T3 (da) Antigen-mærket ikke-infektiös retroviruslignende partikel
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
ATE119042T1 (de) Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion.
PT1159298E (pt) Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
IE881282L (en) Monoclonal antibodies to specific antigenic regions of the¹human immunodeficiency virus and methods for use.
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
EP0320034A3 (de) Synthetische Peptide, die immunologische Aktivität zeigen, benutzbar, um eine Impfung gegen Malaria vorzubereiten
DE69707680D1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv-1 infektion
EP0250128A3 (de) Von AIDS-Patienten isoliertes Virus
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids